Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Alzheimer's Disease

  Free Subscription


Articles published in J Neurol Neurosurg Psychiatry

Retrieve available abstracts of 52 articles:
HTML format



Single Articles


    September 2021
  1. CHONG JR, Ashton NJ, Karikari TK, Tanaka T, et al
    Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances.
    J Neurol Neurosurg Psychiatry. 2021 Sep 11. pii: jnnp-2021-327370.
    PubMed     Abstract available


    June 2021
  2. CHEUNG CY, Mok V, Foster PJ, Trucco E, et al
    Retinal imaging in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2021 Jun 9. pii: jnnp-2020-325347.
    PubMed     Abstract available


    April 2021
  3. SINGLETON E, Hansson O, Pijnenburg YAL, La Joie R, et al
    Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2021 Apr 13. pii: jnnp-2020-325497.
    PubMed     Abstract available


    February 2021
  4. OLIVEIRA FPM, Walker Z, Walker RWH, Attems J, et al
    (123)I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease: a new quantitative analysis of autopsy confirmed cases.
    J Neurol Neurosurg Psychiatry. 2021 Feb 4. pii: jnnp-2020-324606.
    PubMed     Abstract available


    December 2020
  5. HALBGEBAUER S, Oeckl P, Steinacker P, Yilmazer-Hanke D, et al
    Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2020 Dec 30. pii: jnnp-2020-324306.
    PubMed     Abstract available


  6. FULLGRABE C
    When hearing loss masquerades as cognitive decline.
    J Neurol Neurosurg Psychiatry. 2020;91:1248.
    PubMed    


    November 2020
  7. KEIR LHM, Breen DP
    REM sleep behaviour disorder in patients without synucleinopathy.
    J Neurol Neurosurg Psychiatry. 2020;91:1239-1240.
    PubMed    


    October 2020
  8. CHU CS, Li CT, Brunoni AR, Yang FC, et al
    Cognitive effects and acceptability of non-invasive brain stimulation on Alzheimer's disease and mild cognitive impairment: a component network meta-analysis.
    J Neurol Neurosurg Psychiatry. 2020 Oct 28. pii: jnnp-2020-323870.
    PubMed     Abstract available


  9. LU L, Zheng X, Wang S, Tang C, et al
    Anti-Abeta agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2020 Oct 12. pii: jnnp-2020-323497.
    PubMed     Abstract available


  10. KOH W, Lim L, Low A, Wong B, et al
    Development and validation of a brief visual based cognitive screening tool for dementia: the Visual Cognitive Assessment Test short-form (VCAT-S).
    J Neurol Neurosurg Psychiatry. 2020;91:1122-1123.
    PubMed    


    September 2020
  11. AMIN J, Boche D, Clough Z, Teeling J, et al
    Peripheral immunophenotype in dementia with Lewy bodies and Alzheimer's disease: an observational clinical study.
    J Neurol Neurosurg Psychiatry. 2020 Sep 23. pii: jnnp-2020-323603.
    PubMed     Abstract available


  12. LOGROSCINO G
    Prevention of Alzheimer's disease and dementia: the evidence is out there, but new high-quality studies and implementation are needed.
    J Neurol Neurosurg Psychiatry. 2020 Sep 15. pii: jnnp-2020-323606.
    PubMed    


  13. LOW A, Mak E, Malpetti M, Passamonti L, et al
    In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2020 Sep 11. pii: jnnp-2020-323894.
    PubMed     Abstract available


  14. AGIN A, Blanc F, Bousiges O, Villette C, et al
    Environmental exposure to phthalates and dementia with Lewy bodies: contribution of metabolomics.
    J Neurol Neurosurg Psychiatry. 2020;91:968-974.
    PubMed     Abstract available


  15. BENUSSI A, Karikari TK, Ashton N, Gazzina S, et al
    Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration.
    J Neurol Neurosurg Psychiatry. 2020;91:960-967.
    PubMed     Abstract available


    July 2020
  16. YU JT, Xu W, Tan CC, Andrieu S, et al
    Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials.
    J Neurol Neurosurg Psychiatry. 2020 Jul 20. pii: jnnp-2019-321913.
    PubMed     Abstract available


    May 2020
  17. CHEN S, Honda T, Ohara T, Hata J, et al
    Serum homocysteine and risk of dementia in Japan.
    J Neurol Neurosurg Psychiatry. 2020;91:540-546.
    PubMed     Abstract available


  18. SENOVA S, Fomenko A, Gondard E, Lozano AM, et al
    Anatomy and function of the fornix in the context of its potential as a therapeutic target.
    J Neurol Neurosurg Psychiatry. 2020;91:547-559.
    PubMed     Abstract available


    December 2019
  19. GATCHEL JR, Lopera F, Norton DJ, Baena A, et al
    Association of subjective cognitive decline with markers of brain pathology in preclinical autosomal dominant Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2019 Dec 24. pii: jnnp-2019-321205.
    PubMed    


    August 2019
  20. SMITH C, Malek N, Grosset K, Cullen B, et al
    Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies.
    J Neurol Neurosurg Psychiatry. 2019 Aug 23. pii: jnnp-2019-321111.
    PubMed     Abstract available


  21. TEUBER-HANSELMANN S, Rekowski J, Vogelgsang J, von Arnim C, et al
    CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2019 Aug 1. pii: jnnp-2019-321073.
    PubMed     Abstract available


  22. BLENNOW K, Diaz-Lucena D, Zetterberg H, Villar-Pique A, et al
    CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD.
    J Neurol Neurosurg Psychiatry. 2019;90:846-853.
    PubMed     Abstract available


    July 2019
  23. JIA J, Hu J, Huo X, Miao R, et al
    Effects of vitamin D supplementation on cognitive function and blood Abeta-related biomarkers in older adults with Alzheimer's disease: a randomised, double-blind, placebo-controlled trial.
    J Neurol Neurosurg Psychiatry. 2019 Jul 11. pii: jnnp-2018-320199.
    PubMed     Abstract available


    April 2019
  24. FOIANI MS, Cicognola C, Ermann N, Woollacott IOC, et al
    Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest.
    J Neurol Neurosurg Psychiatry. 2019 Apr 13. pii: jnnp-2018-319266.
    PubMed     Abstract available


  25. HOU XH, Feng L, Zhang C, Cao XP, et al
    Models for predicting risk of dementia: a systematic review.
    J Neurol Neurosurg Psychiatry. 2019;90:373-379.
    PubMed     Abstract available


    February 2019
  26. ALCOLEA D, Irwin DJ, Illan-Gala I, Munoz L, et al
    Elevated YKL-40 and low sAPPbeta:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD.
    J Neurol Neurosurg Psychiatry. 2019;90:180-186.
    PubMed     Abstract available


    January 2019
  27. SHEN XN, Niu LD, Wang YJ, Cao XP, et al
    Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies.
    J Neurol Neurosurg Psychiatry. 2019 Jan 10. pii: jnnp-2018-319148.
    PubMed     Abstract available


    December 2018
  28. MOTTA C, Di Lorenzo F, Ponzo V, Pellicciari MC, et al
    Transcranial magnetic stimulation predicts cognitive decline in patients with Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2018;89:1237-1242.
    PubMed     Abstract available


    October 2018
  29. PAWLOWSKI M, Joksch V, Wiendl H, Meuth SG, et al
    Apraxia screening predicts Alzheimer pathology in frontotemporal dementia.
    J Neurol Neurosurg Psychiatry. 2018 Oct 10. pii: jnnp-2018-318470.
    PubMed     Abstract available


    August 2018
  30. SAWADA H, Oeda T, Kohsaka M, Umemura A, et al
    Early use of donepezil against psychosis and cognitive decline in Parkinson's disease: a randomised controlled trial for 2 years.
    J Neurol Neurosurg Psychiatry. 2018 Aug 3. pii: jnnp-2018-318107.
    PubMed     Abstract available


    July 2018
  31. VIK-MO AO, Bencze J, Ballard C, Hortobagyi T, et al
    Advanced cerebral amyloid angiopathy and small vessel disease are associated with psychosis in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2018 Jul 27. pii: jnnp-2018-318445.
    PubMed    


  32. DI LAZZARO V
    Emergence of neurophysiological biomarkers of Alzheimer disease.
    J Neurol Neurosurg Psychiatry. 2018 Jul 21. pii: jnnp-2018-318867.
    PubMed    


    June 2018
  33. KITAMURA S, Shimada H, Niwa F, Endo H, et al
    Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2018 Jun 8. pii: jnnp-2018-317970.
    PubMed     Abstract available


  34. AGARWAL S, Koch G, Hillis AE, Huynh W, et al
    Interrogating cortical function with transcranial magnetic stimulation: insights from neurodegenerative disease and stroke.
    J Neurol Neurosurg Psychiatry. 2018 Jun 4. pii: jnnp-2017-317371.
    PubMed     Abstract available


    January 2018
  35. BOUSIGES O, Bombois S, Schraen S, Wallon D, et al
    Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage.
    J Neurol Neurosurg Psychiatry. 2018 Jan 10. pii: jnnp-2017-316385.
    PubMed     Abstract available


    December 2017
  36. SOUSA ALVES G
    CSF beta-amyloid and white matter damage: unravelling the neuropathology of Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2017 Dec 16. pii: jnnp-2017-317053.
    PubMed    


  37. KING E, O'Brien JT, Donaghy P, Morris C, et al
    Peripheral inflammation in prodromal Alzheimer's and Lewy body dementias.
    J Neurol Neurosurg Psychiatry. 2017 Dec 16. pii: jnnp-2017-317134.
    PubMed     Abstract available


  38. CONNOR JR
    CSF ferritin predicts CSF Abeta decline in biomarker-determined Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2017 Dec 8. pii: jnnp-2017-317050.
    PubMed    


  39. BROWN JM, Lansdall CJ, Wiggins J, Dawson KE, et al
    The Test Your Memory for Mild Cognitive Impairment (TYM-MCI).
    J Neurol Neurosurg Psychiatry. 2017;88:1045-1051.
    PubMed     Abstract available


    November 2017
  40. BANERJEE G, Carare R, Cordonnier C, Greenberg SM, et al
    The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice.
    J Neurol Neurosurg Psychiatry. 2017;88:982-994.
    PubMed     Abstract available


  41. HARPER L, Bouwman F, Burton EJ, Barkhof F, et al
    Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis.
    J Neurol Neurosurg Psychiatry. 2017;88:908-916.
    PubMed     Abstract available


    October 2017
  42. PIETROBONI AM, Scarioni M, Carandini T, Basilico P, et al
    CSF beta-amyloid and white matter damage: a new perspective on Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2017 Oct 20. pii: jnnp-2017-316603.
    PubMed     Abstract available


  43. CARSWELL CJ, Win Z, Muckle K, Kennedy A, et al
    Clinical utility of amyloid PET imaging with (18)F-florbetapir: a retrospective study of 100 patients.
    J Neurol Neurosurg Psychiatry. 2017 Oct 10. pii: jnnp-2017-316194.
    PubMed     Abstract available


    September 2017
  44. AYTON S, Diouf I, Bush AI
    Evidence that iron accelerates Alzheimer's pathology: a CSF biomarker study.
    J Neurol Neurosurg Psychiatry. 2017 Sep 22. pii: jnnp-2017-316551.
    PubMed     Abstract available


  45. DARBY RR, Brickhouse M, Wolk DA, Dickerson BC, et al
    Effects of cognitive reserve depend on executive and semantic demands of the task.
    J Neurol Neurosurg Psychiatry. 2017;88:794-802.
    PubMed     Abstract available


    August 2017
  46. LAI KSP, Liu CS, Rau A, Lanctot KL, et al
    Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies.
    J Neurol Neurosurg Psychiatry. 2017 Aug 9. pii: jnnp-2017-316201.
    PubMed     Abstract available


    July 2017
  47. MCKIERNAN EF, O'Brien JT
    7T MRI for neurodegenerative dementias in vivo: a systematic review of the literature.
    J Neurol Neurosurg Psychiatry. 2017;88:564-574.
    PubMed     Abstract available


    March 2017
  48. WOODHEAD ZV, Crinion J, Teki S, Penny W, et al
    Auditory training changes temporal lobe connectivity in 'Wernicke's aphasia': a randomised trial.
    J Neurol Neurosurg Psychiatry. 2017 Mar 4. pii: jnnp-2016-314621.
    PubMed     Abstract available


    February 2017
  49. PRESSMAN PS, Simpson M, Gola K, Shdo SM, et al
    Observing conversational laughter in frontotemporal dementia.
    J Neurol Neurosurg Psychiatry. 2017 Feb 24. pii: jnnp-2016-314931.
    PubMed     Abstract available


  50. LEMSTRA AW, de Beer MH, Teunissen CE, Schreuder C, et al
    Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies.
    J Neurol Neurosurg Psychiatry. 2017;88:113-118.
    PubMed     Abstract available


    November 2016
  51. FERRARI R, Wang Y, Vandrovcova J, Guelfi S, et al
    Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.
    J Neurol Neurosurg Psychiatry. 2016 Nov 29. pii: jnnp-2016-314411.
    PubMed     Abstract available


  52. AHMED S, Baker I, Thompson S, Husain M, et al
    Utility of testing for apraxia and associated features in dementia.
    J Neurol Neurosurg Psychiatry. 2016;87:1158-1162.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: